Pharmac, the agency that decides which medicines are funded in New Zealand, today said it was looking to widen access to four products as part of the first public consultation following its receipt of an additional NZD$604m ($369m) over four years from the government to fund or widen access to more medicines.
New Zealand Gets Cracking On NZD$604m Drug Funding Boost; Starts Repealing Landmark Law
Two targeted treatments for six different types of cancer and two antifungal drugs are the first products that Pharmac has proposed should be funded after it received a boost to its budget in June. Separately, the government is seeking feedback on a bill to repeal the sweeping new therapeutic products law that was passed by its predecessor.
